Poor agreement between a mobile phone application for the analysis of skin lesions and the clinical diagnosis of the dermatologist, a pilot study

Abstract

The use of mobile phone health applications (apps) has become very popular in the population. The SkinVision app (SVA) is the first skin cancer app with an European CE-certification.¹ This means that a product has met EU health, safety and environmental requirements.² SkinVision lets the consumer "take photos of moles and skin conditions to analyse for skin cancer risk".¹ Artificial intelligence is used to automatically interpret the modified image. Based on this analysis, it evaluates lesions as low (green), medium (yellow) or high risk (red).¹

This article is protected by copyright. All rights reserved.

http://ift.tt/2muf9MF